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INTRODUCTION
Endogenous opioids seem to be involved in maternal adaptation to pregnancy and parturition. Several studies have shown that plasma concentrations of immunoreactive (Ir) ß-endorphin increase in pregnant women, with a progressive trend toward the third trimester (Csontos, Rust, Höllt et al. 1979 ; Genazzani, Facchinetti & Parrini, 1981; Goland, Wardlaw, Stark & Frantz, 1981; Browning, Butt, Lynch & Shakespear, 1983; Newnham, Tomlin, Ratter et al. 1983 ) and a further increase occurs during labour, leading to values approximately tenfold higher (Fletcher, Thomas & Hill, 1980; Facchinetti, Centini, Parrini et al. 1982) . It remains to be demonstrated whether this increase is only related to secretion by the placenta, which is able to synthesize ß-endorphin (Nakai, Nakao, Oki & Imura, 1978; Fraioli & Genazzani, 1980) or is dependent on hypersécrétion in the pituitary gland, the main source of circulating Ir ß-endorphin. It has been reported recently that in lactating rats plasma ß-endorphin levels are higher than in control females (Riskind, Millard & Martin, 1983 ).
ß-Endorphin-secreting cells are present both in the anterior pituitary (AP) and in the neurointermediate pituitary lobe (NIL) and different neuroendocrine con¬ trols regulate their secretion (Vale, Rivier, Yang et al. 1978; Przewlocki, Höllt, Voigt & Herz, 1979 ; Vermes, Mulder, Smelick & Tilders, 1980;  Petraglia, Peñalva, Genazzani & Müller, 1982 ; Lowry, Rosebrough, Farr & Randall (1951) (Greenwood, Hunter & Glover, 1962) and as standard. Anti-camel ß-endorphin (kindly given by Professor A. E. Panerai, Milan, Italy) was used at a final dilution of 1:100 000 for tissue fragments and 1: 120000 for plasma.
The antiserum cross-reacted 100% with ovine ß-endorphin, 30% with human ß-endorphin and 50% with ß-lipotrophin. No cross-reactivity was evident with a-and -endorphin, Leu-and Met-enkephalin, amelanocyte-stimulating hormone ( -MSH), adreno¬ corticotrophin (ACTH), vasopressin, insulin, gluca¬ gon, thyrotrophin-releasing hormone, luteinizing hormone-releasing hormone, bombesin, growth hormone, prolactin, morphine and naloxone. The esti¬ mation of Ir ß-endorphin in tissues (Ogawa, Panerai, Lee et al. 1979 ) and plasma (Petraglia, Peñalva, Locatelli et al. 1982Z») has been reported previously in detail.
Assay sensitivities were 7 and 2 fmol per tube for tissue and plasma radioimmunoassays respectively; inter-and intra-assay coefficients of variation were 10 + 1-5 and 5-0 + 0-5% respectively at 50% binding (seven samples). (Fig. lb) .
Concentrations in lactating rats were of the same magnitude as in non-pregnant controls and significantly (P<001) lower than in pregnant rats (Fig. 16) (Fig. Id) .
Mediobasal hypothalamus
Concentrations of Ir ß-endorphin and Ir Metenkephalin (pmol/mg protein) in the MBH both in mid-(130 + 11 and 17-5+1-15 respectively) and late (12-8+0-51 and 15-8+1-13) gestation were significantly (P<005) higher than in non-pregnant rats (8-1 + 0-80 and 8-9 + 2-01 ) (Fig. 2a, c) . The highest con¬ centrations of Ir ß-endorphin and Ir Met-enkephalin in the MBH were found during delivery (35-5 + 5-88 and 95-9+15-5), which were significantly (i°<0-01) higher than in pregnant (13-9+1-6 and 20-5 + 2 ) or lactating (8-5±1-1 and 100+ 1-8) rats or in controls (9-1+0-4 and 12-2+1-5) (Fig. 2b,d) (Fig. 3) .
Delivering rats showed the highest concentrations (68T +4-4pmol/1), which were significantly (i°<0-01) higher than in pregnant or lactating (46-3 + 6-1 pmol/1) rats; the mean plasma Ir ß-endorphin concentrations of the latter group were higher than those of control rats (Fig. 3) . 
DISCUSSION
Our results indicated that Ir ß-endorphin con¬ centrations increased in plasma, AP and NIL during pregnancy in rats, suggesting that the secretory events of pituitary Ir ß-endorphin-producing cells undergo significant changes during gestation.
The increase in plasma ß-endorphin levels during pregnancy may thus be related to the increased activity of ß-endorphin-producing cells in both pituitary lobes; however, we cannot exclude a possible placental contribution (Nakai et al. 1978; Fraioli & Genazzani, 1980) . The increase of Ir ß-endorphin concentrations in the plasma and pituitary lobes of pregnant rats agrees with the progressive rise in circulating ß-endor¬ phin during pregnancy (Csontos et al. 1979; Genazzani et al. 1981; Goland et al. 1981; Browning et al. 1983; Newnham et al. 1983 ). Since ACTH and ß-lipotrophin, secreted concomitantly with ß-endorphin by corticotroph cells in AP (pro-opiomelanocortinrelated peptides) (McLoughlin, Lowry, Ratter et al. 1980) , also increase in the plasma during pregnancy (Genazzani, Fraioli, Hurlimann et al. 1975; Rees, Burke, Chard et al. 1975; Newnham et al. 1983) (Cholst, Wardlaw & Frantz, 1983) .
Delivering rats showed further increases in Ir ß-endorphin concentration in plasma and AP, without changes in the NIL, thus indicating an important activation of the release of pro-opiomelanocortinrelated peptides from the AP as was indicated also by the significant increase of plasma ACTH in rats during parturition (Voogt, Sar & Meites, 1969) .
It has been shown that the selective ablation of AP abolishes the stress-related mobilization of ß-endorphin into the systemic circulation and both acute and chronic dexamethasone administration alters the stress-induced changes in ß-endorphin levels found in AP and plasma (Przewlocki, Millan, Gramsch et al. 1982; Lim, Oei & Funder, 1983) . These results agree with the progressive rise in plasma ß-endorphin con¬ centrations during human labour, which reach peak values at delivery (Fletcher et al. 1980; Facchinetti et al. 1982) . The observation that Ir ß-endorphin and Ir Met-enkephalin showed the highest hypothalamic concentrations in delivering rats supports the concept that opioid peptides play an important role in stressrelated responses (Adler, 1980 
